Assignee
FOX CHASE CANCER CT
US·28 granted patents·14 pending applications·582 citations·filing 1995–2015
Top patents by PatentIndex Score
42 records- 0196US7618817B2Genetically modified human natural killer cell linesFOX CHASE CANCER CT·Filed 2005·Granted Nov 17, 2009·135 cites·1 claims
- 0295US9181322B2Genetically modified human natural killer cell linesFOX CHASE CANCER CT·Filed 2012·Granted Nov 10, 2015·51 cites·7 claims
- 0393US7919610B2Yeast bacterial two-hybrid system and methods of use thereofFOX CHASE CANCER CT·Filed 2005·Granted Apr 5, 2011·27 cites·7 claims
- 0490US7268358B2Method of modulating laser-accelerated protons for radiation therapyFOX CHASE CANCER CT·Filed 2006·Granted Sep 11, 2007·115 cites·38 claims
- 0590US6391557B1Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereofFOX CHASE CANCER CT·Filed 2000·Granted May 21, 2002·44 cites·8 claims
- 0684US7199122B2Methods for inhibiting angiogenesisFOX CHASE CANCER CT·Filed 2002·Granted Apr 3, 2007·26 cites·32 claims
- 0783US7863029B2Alternate morpheeins of allosteric proteins as a target for the development of bioactive moleculesFOX CHASE CANCER CT·Filed 2008·Granted Jan 4, 2011·4 cites·4 claims
- 0883US7071298B2Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteinsFOX CHASE CANCER CT·Filed 2001·Granted Jul 4, 2006·13 cites·3 claims
- 0982US6699980B1Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereofFOX CHASE CANCER CT·Filed 2000·Granted Mar 2, 2004·10 cites·12 claims
- 1081US7755068B2Laser-accelerated proton therapy units and superconducting electromagnet systems for sameFOX CHASE CANCER CT·Filed 2005·Granted Jul 13, 2010·36 cites·34 claims
- 1181US7615528B2Methods for alleviating deleterious effects of 3-deoxyglucosoneFOX CHASE CANCER CT·Filed 2005·Granted Nov 10, 2009·5 cites·8 claims
- 1278US7491807B2Gene encoding a DNA repair enzyme and methods of use thereofFOX CHASE CANCER CT·Filed 2007·Granted Feb 17, 2009·2 cites·9 claims
- 1376US7452884B2Methods for inhibiting angiogenesisFOX CHASE CANCER CT·Filed 2006·Granted Nov 18, 2008·3 cites·5 claims
- 1476US6599700B1Methods for detection of transition single-nucleotide polymorphismsFOX CHASE CANCER CT·Filed 2000·Granted Jul 29, 2003·4 cites·5 claims
- 1574US7781568B2Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancerFOX CHASE CANCER CT·Filed 2006·Granted Aug 24, 2010·2 cites·17 claims
- 1674US7317192B2High energy polyenergetic ion selection systems, ion beam therapy systems, and ion beam treatment centersFOX CHASE CANCER CT·Filed 2004·Granted Jan 8, 2008·76 cites·60 claims
- 1773US7416840B2Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cellsFOX CHASE CANCER CT·Filed 2003·Granted Aug 26, 2008·3 cites·23 claims
- 1873US7208583B2Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereofFOX CHASE CANCER CT·Filed 2003·Granted Apr 24, 2007·2 cites·4 claims
- 1969US7053194B2Compositions and methods for p53-mediated repression of gene expressionFOX CHASE CANCER CT·Filed 2002·Granted May 30, 2006·2 cites·36 claims
- 2067US7829671B2Gene encoding a DNA repair enzyme and methods of use thereofFOX CHASE CANCER CT·Filed 2009·Granted Nov 9, 2010·0 cites·4 claims
- 2164US2008247990A1Genetically modified human natural killer cell linesFOX CHASE CANCER CT·Filed 2008·Application pending·0 cites
- 2257US7312026B2MRP-related ABC transporter encoding nucleic acids and methods of use thereofFOX CHASE CANCER CT·Filed 2004·Granted Dec 25, 2007·0 cites·15 claims
- 2357US2016067356A1Genetically modified human natural killer cell linesFOX CHASE CANCER CT·Filed 2015·Application pending·0 cites
- 2454US2015080252A1Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancerFOX CHASE CANCER CT·Filed 2014·Application pending·0 cites
- 2553US2013331294A1Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CT·Filed 2013·Application pending·0 cites
- 2652US6326150B1Yeast interaction trap assayFOX CHASE CANCER CT·Filed 1998·Granted Dec 4, 2001·15 cites·21 claims
- 2752US2011172107A1Assay for identifying agents that modulate epigenetic silencing, and agents identified therebyFOX CHASE CANCER CT·Filed 2009·Application pending·0 cites
- 2851US7736848B2Cellular targets for treatment of retroviral infectionFOX CHASE CANCER CT·Filed 2005·Granted Jun 15, 2010·0 cites·8 claims
- 2951US7705021B2Isoindolone compounds, compositions containing the same, and methods of use thereof for the treatment of viral infections related to the etiology of cancerFOX CHASE CANCER CT·Filed 2006·Granted Apr 27, 2010·0 cites·11 claims
- 3048US2014050665A1Method for the treatment or prophylaxis of lymphangioleiomyomatosis (lam) and animal model for use in lam researchFOX CHASE CANCER CT·Filed 2013·Application pending·0 cites
- 3145US2011198516A1Shielding for compact radiation sourcesFOX CHASE CANCER CT·Filed 2008·Application pending·0 cites
- 3245US2011110925A1Compositions and Methods for the Treatment and Diagnosis of CancerFOX CHASE CANCER CT·Filed 2010·Application pending·0 cites
- 3344US2011207816A1Alternate morpheeins of allosteric proteins as a target for the development of bioactive moleculesFOX CHASE CANCER CT·Filed 2010·Application pending·0 cites
- 3443US2011086423A1Cellular Targets for Treatment of Retroviral InfectionFOX CHASE CANCER CT·Filed 2010·Application pending·0 cites
- 3539US2014272947A1Methods and compositions for screening modulators of oncogene-induced senescenceFOX CHASE CANCER CT·Filed 2014·Application pending·0 cites
- 3638US2013004504A1Method of modulating phenylalanine hydroxylase structure and functionFOX CHASE CANCER CT·Filed 2012·Application pending·0 cites
- 3737US6653074B1Methods for identifying agents which affect cellular morphology, locomotion and deathFOX CHASE CANCER CT·Filed 2000·Granted Nov 25, 2003·0 cites·4 claims
- 3834US6150511AChimeric enzyme for promoting targeted integration of foreign DNA into a host genomeFOX CHASE CANCER CT·Filed 1995·Granted Nov 21, 2000·2 cites·5 claims
- 3934US2009230318A1Target design for high-power laser accelerated ionsFOX CHASE CANCER CT·Filed 2005·Application pending·0 cites
- 4029US6803184B1MPR-related ABC transporter encoding nucleic acids and methods of use thereofFOX CHASE CANCER CT·Filed 1999·Granted Oct 12, 2004·3 cites·15 claims
- 4128US6593098B1Genes encoding proteins involved in mitotic checkpoint control and methods of use thereofFOX CHASE CANCER CT·Filed 1998·Granted Jul 15, 2003·2 cites·30 claims
- 4227US2004111220A1Methods of decomposing complex dataFOX CHASE CANCER CT·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FOX CHASE CANCER CT files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →